Taxotere Earns Approval For Advanced Stomach Cancer
Sanofi-Aventis's Taxotere (docetaxel) has added an indication for advanced stomach cancer. The antineoplastic agent cleared FDA with its sixth indication March 22
Sanofi-Aventis's Taxotere (docetaxel) has added an indication for advanced stomach cancer. The antineoplastic agent cleared FDA with its sixth indication March 22